Iron deficiency anemia (IDA)
Iron deficiency is the most common cause of anemia in the world.1 It is common in women who are in their child-bearing years because of the increased amount of iron needed during menstruation, pregnancy, and breastfeeding.1 If you or someone you love have been told you are iron deficient, read here to understand what the condition is all about.
What to look for in an iron formulation
All iron formulations are designed to replace the iron your system loses. There are important differences, however, in how various types of iron work. These differences can make iron easier or harder on your system.
A choice that restores your body's iron the biocomplementary way
Ferralet® 90 is a unique prescription iron therapy that works in sync with your system to make taking iron a more gentle experience. Ferralet 90 has been designed to make taking iron more pleasant for you as your iron stores are safely and gradually restored.
Many oral iron formulations are available—by prescription as well as over-the-counter. But they are not all alike in how they act in your body. What makes Ferralet 90® different? First, it contains Ferr-Ease™*, a unique, patented, dual-iron formulation not available in any other oral iron product. Ferr-Ease is in sync with the way the body absorbs iron, providing ferrous gluconate for immediate release and carbonyl iron for gentle and prolonged action.
Beyond dual iron, Ferralet 90 also contains several ingredients designed to make your experience with taking iron more effective and pleasant.
Important Safety Information
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Warning
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions
Administration of Drug- General: Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. The type of anemia and underlying cause or causes should be determined before starting therapy with Ferralet® 90 tablets. Ensure Hgb, Hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. Periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
- Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using these products since folic acid may mask the symptoms of pernicious anemia.
- Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use: Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.
This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.
Please see full Prescribing Information
* US Patent no. 6,521,247 B1
- Barton JC. Iron deficiency. In Rakel RE, Bope ET. Conn's Current Therapy, 2008. Amsterdam, The Netherlands: Saunders/Elsevier, 385-389.
